Diabetes drug Invokana under scrutiny

Beerse, Belgium-based Janssen Pharmaceutical’s top-selling diabetes drug Invokana (canagli­flozin) continued to come under scrutiny in April and May with new lawsuits filed, along with questioning from the European Medicines Agency (EMA) about serious potential adverse effects.

read more

JAS acquires Empi Advance ROM line

Effingham, IL-based Joint Active Systems (JAS) reported on May 3 that it has acquired the Empi Advance ROM line of dynamic braces from Empi, a subsidiary of San Diego-based DJO Global. JAS plans to reintroduce the Empi Advance ROM line by July.

read more

Join

Subscribe For Updates

Stay in the loop with the latest news and updates! Subscribe now to receive exclusive content, special offers, and important announcements straight to your inbox. Don’t miss out – join our community today for all the latest updates delivered directly to you.